pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Kenya confirms second Ebola case as Congo outbreak continues

Oct 15, 2026·read at STAT ↗Negative

Kenya health officials have confirmed a second case of Ebola in the country, raising concerns about potential spread.

The report comes as the neighboring Democratic Republic of Congo continues to battle a severe outbreak, with officials citing more than 4,000 deaths and around 9,000 confirmed infections.

Health authorities in both nations are intensifying surveillance and response measures, while international agencies monitor the situation closely.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Kenya reports second Ebola case”

read at STAT ↗
1,108 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
JOURNEYNorthwestern University
topics
Oncology3Psychiatry & CNS2GLP-1 receptorVaccineWomen's Health

related stories

  • Sep 9Telemedicine company offers GLP-1s for addictionSTAT
  • Oct 1Top journal’s special issue on women’s health casts spotlight on menopause and painSTAT
  • Jul 20HHS vaccine committee quietly gets new charterSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 6Opinion: How the Amish think about vaccines, health care costs, and much moreSTAT